Skip to main content

Table 1 Patient characteristics (n = 44)

From: A phase II trial to assess the activity of gemcitabine and docetaxel as first line chemotherapy treatment in patients with unresectable leiomyosarcoma

 

N

%

Age (years)

 Median

53

 

 Range

31–73

 

Sex

 Male

5

11.4

 Female

39

88.6

Primary site of disease

 Uterus

24

54.5

 Retroperitoneum

7

15.9

 Other

7

15.9

 Extremity

2

4.5

 Vascular

2

4.5

 Thoracic

1

2.3

 Not known

1

2.3

Disease type

 Locally advanced

5

11.4

 Metastatic

39

88.6

Tumour grade

 Grade 1

6

13.6

 Grade 2

10

22.7

 Grade 3

23

52.3

 Not known

5

11.4

Site of metastases

 Lung

31

70.4

 Liver

17

38.6

 Soft tissue

17

38.6

 Viscera

6

13.6

 Bone

4

9.1

 None

5

11.3

Number of metastatic sites

 0

5

11.3

 1

16

26.4

 2

13

29.5

 3

8

18.2

 4

2

4.5

Previous radiotherapy

 None

30

68.2

 Pelvic

9

20.5

 Other site

5

11.4

Previous surgery

 Yes

36

81.8

 No

8

18.2